<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="782" width="593">
	<fontspec id="font0" size="9" family="AdvC2866" color="#000000"/>
	<fontspec id="font1" size="9" family="AdvPSMP13" color="#000000"/>
	<fontspec id="font2" size="6" family="AdvC2866" color="#000000"/>
	<fontspec id="font3" size="9" family="AdvC2867" color="#000000"/>
	<fontspec id="font4" size="10" family="AdvPSMy-R" color="#000000"/>
	<fontspec id="font5" size="10" family="AdvPSMy-B" color="#000000"/>
	<fontspec id="font6" size="9" family="AdvP4C4E74" color="#000000"/>
	<fontspec id="font7" size="8" family="AdvPSMy-B" color="#000000"/>
	<fontspec id="font8" size="8" family="AdvPSMy-R" color="#000000"/>
<text top="364" left="45" width="243" height="8" font="font0" id="p1_t1" reading_order_no="4" segment_no="4" tag_type="text">not curable, most easily preventable. Data were double</text>
<text top="375" left="45" width="243" height="8" font="font0" id="p1_t2" reading_order_no="5" segment_no="4" tag_type="text">entered by different entry clerks and compared for consis-</text>
<text top="386" left="45" width="243" height="8" font="font0" id="p1_t3" reading_order_no="6" segment_no="4" tag_type="text">tency using EpiInfo version 3.3.2 (Centers for Disease Control</text>
<text top="397" left="45" width="243" height="8" font="font0" id="p1_t4" reading_order_no="7" segment_no="4" tag_type="text">and Prevention [http://www.cdc.gov/EpiInfo]). Statistical anal-</text>
<text top="409" left="45" width="243" height="8" font="font0" id="p1_t5" reading_order_no="8" segment_no="4" tag_type="text">ysis was conducted using Stata version 8.2 (Stata Corporation</text>
<text top="418" left="45" width="243" height="10" font="font0" id="p1_t6" reading_order_no="9" segment_no="4" tag_type="text">[http://www.stata.com]). Pearson v 2 was used to assess the age</text>
<text top="431" left="45" width="243" height="8" font="font0" id="p1_t7" reading_order_no="10" segment_no="4" tag_type="text">and sex distribution of the sample population. Conﬁdence</text>
<text top="442" left="45" width="243" height="8" font="font0" id="p1_t8" reading_order_no="11" segment_no="4" tag_type="text">intervals for the point estimates were derived using the</text>
<text top="453" left="45" width="243" height="8" font="font0" id="p1_t9" reading_order_no="12" segment_no="4" tag_type="text">Huber/White sandwich estimator of variance to adjust for</text>
<text top="464" left="45" width="243" height="8" font="font0" id="p1_t10" reading_order_no="13" segment_no="4" tag_type="text">clustering effects at the household level [16]. Sensitivity</text>
<text top="476" left="45" width="243" height="8" font="font0" id="p1_t11" reading_order_no="14" segment_no="4" tag_type="text">analysis of the prevalence estimates was undertaken by</text>
<text top="487" left="45" width="243" height="8" font="font0" id="p1_t12" reading_order_no="15" segment_no="4" tag_type="text">including all the enumerated persons in the denominator</text>
<text top="498" left="45" width="243" height="8" font="font0" id="p1_t13" reading_order_no="16" segment_no="4" tag_type="text">under the assumption that the absentees had no visual</text>
<text top="509" left="45" width="243" height="8" font="font0" id="p1_t14" reading_order_no="17" segment_no="4" tag_type="text">impairment; and the size of the change in prevalence</text>
<text top="520" left="45" width="243" height="8" font="font0" id="p1_t15" reading_order_no="18" segment_no="4" tag_type="text">estimates assessed. Inter-rater agreement of eye examination</text>
<text top="532" left="45" width="243" height="8" font="font0" id="p1_t16" reading_order_no="19" segment_no="4" tag_type="text">(VA and determination of cause) was assessed using the kappa</text>
<text top="542" left="45" width="243" height="9" font="font3" id="p1_t17" reading_order_no="20" segment_no="4" tag_type="text">( j ) statistic [17]. To derive population estimates of burden,</text>
<text top="554" left="45" width="243" height="8" font="font0" id="p1_t18" reading_order_no="21" segment_no="4" tag_type="text">prevalence estimates were adjusted for age and sex according</text>
<text top="565" left="45" width="243" height="8" font="font0" id="p1_t19" reading_order_no="22" segment_no="4" tag_type="text">to the sample population structure. The 95% conﬁdence</text>
<text top="576" left="45" width="243" height="8" font="font0" id="p1_t20" reading_order_no="23" segment_no="4" tag_type="text">intervals (CIs) of the adjusted prevalence estimates were</text>
<text top="587" left="45" width="243" height="8" font="font0" id="p1_t21" reading_order_no="24" segment_no="4" tag_type="text">multiplied by the population estimates to derive the lower</text>
<text top="599" left="45" width="243" height="8" font="font0" id="p1_t22" reading_order_no="25" segment_no="4" tag_type="text">and upper bounds of those with blindness, low vision, and</text>
<text top="610" left="45" width="121" height="8" font="font0" id="p1_t23" reading_order_no="26" segment_no="4" tag_type="text">monocular visual impairment.</text>
<text top="628" left="45" width="93" height="9" font="font4" id="p1_t24" reading_order_no="27" segment_no="9" tag_type="title">Ethical Considerations</text>
<text top="640" left="54" width="234" height="8" font="font0" id="p1_t25" reading_order_no="28" segment_no="10" tag_type="text">The Sudan People’s Liberation Movement Secretariat of</text>
<text top="652" left="45" width="243" height="8" font="font0" id="p1_t26" reading_order_no="29" segment_no="10" tag_type="text">Health (SPLM/Health) approved the protocol, and clearance</text>
<text top="663" left="45" width="243" height="8" font="font0" id="p1_t27" reading_order_no="30" segment_no="10" tag_type="text">to conduct the surveys was obtained from the local author-</text>
<text top="674" left="45" width="243" height="8" font="font0" id="p1_t28" reading_order_no="31" segment_no="10" tag_type="text">ities. Verbal consent to participate was sought from the head</text>
<text top="685" left="45" width="243" height="8" font="font0" id="p1_t29" reading_order_no="32" segment_no="10" tag_type="text">of the household, and from each individual, and the parents</text>
<text top="696" left="45" width="243" height="8" font="font0" id="p1_t30" reading_order_no="33" segment_no="10" tag_type="text">of small children in accordance with the declaration of</text>
<text top="707" left="45" width="243" height="8" font="font0" id="p1_t31" reading_order_no="34" segment_no="10" tag_type="text">Helsinki. Personal identiﬁers were removed from the dataset</text>
<text top="719" left="45" width="133" height="8" font="font0" id="p1_t32" reading_order_no="35" segment_no="10" tag_type="text">before analyses were undertaken.</text>
<text top="363" left="306" width="34" height="10" font="font5" id="p1_t33" reading_order_no="36" segment_no="3" tag_type="title">Results</text>
<text top="379" left="306" width="80" height="9" font="font4" id="p1_t34" reading_order_no="37" segment_no="5" tag_type="title">Sample Population</text>
<text top="391" left="315" width="234" height="8" font="font0" id="p1_t35" reading_order_no="38" segment_no="6" tag_type="text">Twenty two villages (clusters) were sampled and 529</text>
<text top="402" left="306" width="243" height="8" font="font0" id="p1_t36" reading_order_no="39" segment_no="6" tag_type="text">households visited. The mean household size was 7.5 (stand-</text>
<text top="412" left="306" width="243" height="9" font="font0" id="p1_t37" reading_order_no="40" segment_no="6" tag_type="text">ard deviation [SD] ¼ 2.5) with household size ranging from</text>
<text top="424" left="306" width="243" height="8" font="font0" id="p1_t38" reading_order_no="41" segment_no="6" tag_type="text">three to 16 persons. A total of 2,499 persons aged 5 y and</text>
<text top="435" left="306" width="243" height="8" font="font0" id="p1_t39" reading_order_no="42" segment_no="6" tag_type="text">above underwent VA testing and basic eye examination out of</text>
<text top="446" left="306" width="243" height="8" font="font0" id="p1_t40" reading_order_no="43" segment_no="6" tag_type="text">2,954 persons enumerated, a response rate of 84.6%. Of the</text>
<text top="457" left="306" width="243" height="8" font="font0" id="p1_t41" reading_order_no="44" segment_no="6" tag_type="text">2,499 persons included in the analysis, 1,038 (41.5%) were</text>
<text top="468" left="306" width="243" height="8" font="font0" id="p1_t42" reading_order_no="45" segment_no="6" tag_type="text">males and 1,461 (58.5%) were females (Table 1). The age and</text>
<text top="479" left="306" width="243" height="8" font="font0" id="p1_t43" reading_order_no="46" segment_no="6" tag_type="text">sex distribution among the 454 persons not examined was the</text>
<text top="490" left="306" width="243" height="8" font="font0" id="p1_t44" reading_order_no="47" segment_no="6" tag_type="text">same; however, there were more females than males aged 15 y</text>
<text top="499" left="306" width="243" height="10" font="font0" id="p1_t45" reading_order_no="48" segment_no="6" tag_type="text">and above among persons examined (Pearson v 2 ¼ 41.1; p -</text>
<text top="511" left="306" width="243" height="9" font="font0" id="p1_t46" reading_order_no="49" segment_no="6" tag_type="text">value ¼ 0.001). The age range was 5 y to 80 y, with a mean age</text>
<text top="522" left="306" width="84" height="9" font="font0" id="p1_t47" reading_order_no="50" segment_no="6" tag_type="text">of 23.9 y (SD ¼ 16.6).</text>
<text top="541" left="306" width="243" height="9" font="font4" id="p1_t48" reading_order_no="51" segment_no="7" tag_type="title">Prevalence of Blindness, Low Vision, and Monocular Visual</text>
<text top="553" left="306" width="49" height="9" font="font4" id="p1_t49" reading_order_no="52" segment_no="7" tag_type="title">Impairment</text>
<text top="565" left="315" width="234" height="8" font="font0" id="p1_t50" reading_order_no="53" segment_no="8" tag_type="text">The age/sex-speciﬁc and overall prevalence of blindness,</text>
<text top="576" left="306" width="243" height="8" font="font0" id="p1_t51" reading_order_no="54" segment_no="8" tag_type="text">low vision, and monocular visual impairment found in this</text>
<text top="587" left="306" width="243" height="8" font="font0" id="p1_t52" reading_order_no="55" segment_no="8" tag_type="text">study are shown in Figure 2 and Table 2. Overall prevalence</text>
<text top="598" left="306" width="243" height="8" font="font0" id="p1_t53" reading_order_no="56" segment_no="8" tag_type="text">of blindness (VA of less than 3/60 in the better eye) was 4.1%</text>
<text top="609" left="306" width="243" height="8" font="font0" id="p1_t54" reading_order_no="57" segment_no="8" tag_type="text">(95% CI, 3.4–4.8). Prevalence of low vision (VA of at least 3/60</text>
<text top="620" left="306" width="243" height="8" font="font0" id="p1_t55" reading_order_no="58" segment_no="8" tag_type="text">but less than 6/18 in the better eye) was 7.7% (95% CI, 6.7–</text>
<text top="631" left="306" width="243" height="8" font="font0" id="p1_t56" reading_order_no="59" segment_no="8" tag_type="text">8.7); whereas prevalence of monocular visual impairment (VA</text>
<text top="642" left="306" width="243" height="8" font="font0" id="p1_t57" reading_order_no="60" segment_no="8" tag_type="text">of at least 6/18 in the better eye and VA less than 6/18 in the</text>
<text top="653" left="306" width="243" height="8" font="font0" id="p1_t58" reading_order_no="61" segment_no="8" tag_type="text">other eye) was 4.4% (95% CI, 3.6–5.3). Prevalence of blindness</text>
<text top="664" left="306" width="243" height="8" font="font0" id="p1_t59" reading_order_no="62" segment_no="8" tag_type="text">and low vision increased in both males and females with age.</text>
<text top="675" left="306" width="243" height="8" font="font0" id="p1_t60" reading_order_no="63" segment_no="8" tag_type="text">There were no differences between the sexes in the odds of</text>
<text top="685" left="306" width="243" height="9" font="font0" id="p1_t61" reading_order_no="64" segment_no="8" tag_type="text">blindness (odds ratio [OR] ¼ 1.38; 95% CI, 0.92–2.06), low</text>
<text top="696" left="306" width="243" height="9" font="font0" id="p1_t62" reading_order_no="65" segment_no="8" tag_type="text">vision (OR ¼ 1.12; 95% CI, 0.82–1.53), and monocular visual</text>
<text top="707" left="306" width="243" height="9" font="font0" id="p1_t63" reading_order_no="66" segment_no="8" tag_type="text">impairment (OR ¼ 0.90; 95% CI, 0.60–1.33). Sensitivity</text>
<text top="719" left="306" width="243" height="8" font="font0" id="p1_t64" reading_order_no="67" segment_no="8" tag_type="text">analysis of prevalence estimates by including 454 absentees</text>
<text top="319" left="45" width="323" height="7" font="font7" id="p1_t65" reading_order_no="1" segment_no="1" tag_type="text">Figure 2. Age and Sex Distribution of Blindness, Low Vision, and Monocular Visual Impairment</text>
<text top="330" left="45" width="133" height="7" font="font8" id="p1_t66" reading_order_no="2" segment_no="1" tag_type="text">Left graph, males; right graph, females.</text>
<text top="339" left="45" width="134" height="7" font="font8" id="p1_t67" reading_order_no="3" segment_no="2" tag_type="text">doi:10.1371/journal.pmed.0030477.g002</text>
<text top="742" left="69" width="133" height="7" font="font8" id="p1_t68" reading_order_no="68" segment_no="11" tag_type="text">PLoS Medicine | www.plosmedicine.org</text>
<text top="742" left="398" width="151" height="7" font="font8" id="p1_t69" reading_order_no="70" segment_no="12" tag_type="text">December 2006 | Volume 3 | Issue 12 | e477</text>
<text top="742" left="289" width="16" height="7" font="font8" id="p1_t70" reading_order_no="69" segment_no="13" tag_type="text">2419</text>
<text top="26" left="452" width="97" height="7" font="font8" id="p1_t71" reading_order_no="0" segment_no="0" tag_type="title">Blindness in Southern Sudan</text>
</page>
</pdf2xml>
